acromegaly

Crinetics pads case for oral hormone disorder drug

Crinetics' oral med regulated levels of a hormone associated with acromegaly in a phase 3 test, setting up a regulatory submission in the second half.

Annalee Armstrong Mar 19, 2024 9:30am

Crinetics soars as oral rare disease drug meets standard of care

Sep 11, 2023 7:16am

Ionis' midphase misses send rare disease prospects to the abyss

May 4, 2023 10:25am

Midatech ‘urgently’ needs investor as cash reserves dwindle

Jan 25, 2019 10:45am

Endocrine specialist Crinetics tees up for $86M IPO

Jun 25, 2018 8:15am

Crinetics raises $63.5M for oral acromegaly therapy

Mar 14, 2018 9:10am